Synergy IB Investment

Synergy IB Investment, founded in 2014 and based in Seoul, South Korea, is a mezzanine investment firm that focuses on financial analysis, cost management, and profitability. The company primarily seeks investment opportunities in the technology and healthcare sectors, including health tech. Synergy IB Investment engages in private equity and venture capital investments, aiming to support the growth of companies within these dynamic industries.

Jeong Ahn-sik

CEO

9 past transactions

Eastech

Seed Round in 2022
Eastech is a company that specializes in the research and development of drug substance candidates using 3D structural information analysis.

Cigro

Seed Round in 2022
Cigro provides a data integration solution for e-commerce operators.

LyseNTech

Series A in 2021
LyseNTech is a bacteriophage company that develops antibiotic-resistant bacteria.

Larchive

Angel Round in 2021
Larchive monitors import and export supply chains for risk management through its intelligence services.

Rznomics

Series B in 2021
This is a biotechnology company founded by professor Lee Sung-wook's lab They are working on the development of gene therapy products for liver cancer through the development of gene therapy products. It was selected by the TIPS program and was recognized for excellence in technology.

CK Regeon

Series B in 2021
CK Regeon is a biotechnology company that develops drugs with MOA.

SnackFever

Seed Round in 2019
SnackFever Inc. is a subscription-based e-commerce company based in Los Angeles, California, that specializes in delivering a variety of snacks, candies, drinks, and ramen products to customers across the United States. Founded in 2015, SnackFever focuses on providing unique and popular treats that cater to the tastes of its subscribers, contributing to the growing interest in global snack culture. The company aims to create a community around its offerings, drawing inspiration from the global Hallyu wave, which emphasizes the enjoyment of Korean culture and products.

Rznomics

Series A in 2019
This is a biotechnology company founded by professor Lee Sung-wook's lab They are working on the development of gene therapy products for liver cancer through the development of gene therapy products. It was selected by the TIPS program and was recognized for excellence in technology.

AptaBio Therapeutics

Series B in 2018
AptaBio Therapeutics is a pharmaceutical biotechnology company that develops intractable innovative drugs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.